The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-[2-(1,1-Dioxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylquinolin-4-yl]-2-methylpropane-1,2-diamine ID: ALA4161097
PubChem CID: 145957681
Max Phase: Preclinical
Molecular Formula: C24H29FN4
Molecular Weight: 392.52
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2nc(N3CCCc4ccc(F)cc4C3)cc(NCC(C)(C)N)c2c1
Standard InChI: InChI=1S/C24H29FN4/c1-16-6-9-21-20(11-16)22(27-15-24(2,3)26)13-23(28-21)29-10-4-5-17-7-8-19(25)12-18(17)14-29/h6-9,11-13H,4-5,10,14-15,26H2,1-3H3,(H,27,28)
Standard InChI Key: NUKVNAZPOFEYSG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
18.5436 -10.3635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1392 -9.6577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7302 -10.3609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7315 -12.1202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4412 -11.7108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4383 -10.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7297 -10.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0235 -11.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0257 -10.8935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3198 -10.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6111 -10.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6128 -11.7129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3193 -12.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1495 -12.1183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7262 -9.6657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4322 -9.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8476 -9.2480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8174 -11.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0865 -12.9336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6887 -13.4881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4970 -13.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5982 -11.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9048 -12.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7131 -12.7664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2157 -12.1213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9043 -11.3616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0968 -11.2528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9033 -10.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4039 -10.7149 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 8 2 0
5 14 1 0
7 15 1 0
15 16 1 0
16 2 1 0
2 17 1 0
14 18 1 0
18 22 1 0
14 19 1 0
19 20 1 0
23 21 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
11 28 1 0
26 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.52Molecular Weight (Monoisotopic): 392.2376AlogP: 4.78#Rotatable Bonds: 4Polar Surface Area: 54.18Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.15CX LogP: 5.07CX LogD: 0.98Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.35
References 1. Zheng X, Liang C, Wang L, Wang B, Liu Y, Feng S, Wu JZ, Gao L, Feng L, Chen L, Guo T, Shen HC, Yun H.. (2018) Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors., 61 (22): [PMID:30339388 ] [10.1021/acs.jmedchem.8b01394 ]